Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Hsu

Showing results (211-220 of 288) with videos related to

Pageof 29
Sort By:
Retina (Philadelphia, Pa.)|June 3, 2015
INCIDENCE OF SUSTAINED OCULAR HYPERTENSION USING PREPACKAGED VERSUS FRESHLY PREPARED INTRAVITREAL BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONPhilip P Storey, Vincent Ho, Steven Yeh, et al.
American Journal of Ophthalmology|July 20, 2021
Outcomes of Eyes With Diabetic Macular Edema That Are Lost to Follow-up After Anti-Vascular Endothelial Growth Factor TherapyDouglas R Matsunaga, Mirataollah Salabati, Anthony Obeid, et al.
Ophthalmology. Retina|April 1, 2021
Epiretinal Membrane Surgery after Retinal Detachment Repair: Visual Acuity Outcomes and OCT AnalysisRebecca Russ Soares, Raziyeh Mahmoudzadeh, Mirataollah Salabati, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 22, 2024
Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal InjectionAsad F Durrani, Bita Momenaei, Viren Soni, et al.
Eye (London, England)|March 25, 2023
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialSunil S Patel, David R Lally, Jason Hsu, et al.
Eye (London, England)|May 26, 2023
Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialSunil S Patel, David R Lally, Jason Hsu, et al.
Ophthalmology|August 6, 2018
Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth FactorAnthony Obeid, Daniel Su, Samir N Patel, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|October 18, 2021
Barriers to Follow-Up Retinal Care During the COVID-19 Pandemic: A Survey StudyCharlotte N Shields, Elliot G Cherkas, Nikita Mokhashi, et al.
Ophthalmology|July 3, 2024
Retinal Tear and Retinal Detachment after Cataract Surgery in Eyes with a Previous History of Treated Phakic Retinal TearsBita Momenaei, Andrew Zhou, Adina S Kazan, et al.
Journal of Vitreoretinal Diseases|November 17, 2025
Short-Term Changes in Intraocular Pressure Following Intravitreal Injection of PegcetacoplanBita Momenaei, Taku Wakabayashi, Olufemi E Adams, et al.
Pageof 29

Showing results (211-220 of 288) with videos related to

Sort By:
Pageof 29
Retina (Philadelphia, Pa.)|June 3, 2015
INCIDENCE OF SUSTAINED OCULAR HYPERTENSION USING PREPACKAGED VERSUS FRESHLY PREPARED INTRAVITREAL BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONPhilip P Storey, Vincent Ho, Steven Yeh, et al.
American Journal of Ophthalmology|July 20, 2021
Outcomes of Eyes With Diabetic Macular Edema That Are Lost to Follow-up After Anti-Vascular Endothelial Growth Factor TherapyDouglas R Matsunaga, Mirataollah Salabati, Anthony Obeid, et al.
Ophthalmology. Retina|April 1, 2021
Epiretinal Membrane Surgery after Retinal Detachment Repair: Visual Acuity Outcomes and OCT AnalysisRebecca Russ Soares, Raziyeh Mahmoudzadeh, Mirataollah Salabati, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 22, 2024
Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal InjectionAsad F Durrani, Bita Momenaei, Viren Soni, et al.
Eye (London, England)|March 25, 2023
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialSunil S Patel, David R Lally, Jason Hsu, et al.
Eye (London, England)|May 26, 2023
Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialSunil S Patel, David R Lally, Jason Hsu, et al.
Ophthalmology|August 6, 2018
Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth FactorAnthony Obeid, Daniel Su, Samir N Patel, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|October 18, 2021
Barriers to Follow-Up Retinal Care During the COVID-19 Pandemic: A Survey StudyCharlotte N Shields, Elliot G Cherkas, Nikita Mokhashi, et al.
Ophthalmology|July 3, 2024
Retinal Tear and Retinal Detachment after Cataract Surgery in Eyes with a Previous History of Treated Phakic Retinal TearsBita Momenaei, Andrew Zhou, Adina S Kazan, et al.
Journal of Vitreoretinal Diseases|November 17, 2025
Short-Term Changes in Intraocular Pressure Following Intravitreal Injection of PegcetacoplanBita Momenaei, Taku Wakabayashi, Olufemi E Adams, et al.
Pageof 29